Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
August 15 2013 - 12:23PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC FILE NUMBER:
|
000-53678
|
(Check One):
|
o
|
Form 10-K
|
o
|
Form 20-F
|
o
|
Form 11-K
|
x
|
Form 10-Q
|
o
|
Form N-SAR
|
o
|
Form N-CSR
|
For Period Ended:
June 30, 2013
|
o
|
Transition Report on Form 10-K
|
|
o
|
Transition Report on Form 20-F
|
|
o
|
Transition Report on Form 11-K
|
|
o
|
Transition Report on Form 10-Q
|
|
o
|
Transition Report on Form N-SAR
|
For the Transition Period Ended:
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
|
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART I -- REGISTRANT INFORMATION
Biozoom, Inc.
Full Name of Registrant
|
Entertainment Art, Inc.
Former Name if Applicable
|
|
Wilhelmshoeher Allee 273A
Address of Principal Executive Office
(Street and Number)
|
|
Kassel, Germany, D-34131
City, State and Zip Code
|
PART II -- RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
|
|
(a)
|
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
x
|
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K or Form N-SAR, or portion thereof will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
|
|
|
|
|
(c)
|
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART III -- NARRATIVE
State below in reasonable detail the reasons why Forms 10-Q, 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report portion thereof, could not be filed within the prescribed time period.
Registrant did not obtain all the necessary information prior to the filing date, the accountant could not complete the required financial statements, and management could not complete the Managements Discussion and Analysis of such financial statements prior to the filing deadline.
PART IV-- OTHER INFORMATION
(1)
|
Name and telephone number of person to contact in regard to this notification
|
|
Hardy Hoheisel
|
|
800
|
|
882-1683
|
|
|
(Name)
|
|
(Area Code)
|
|
(Telephone Number)
|
|
(2)
|
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
|
(3)
|
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
Biozoom, Inc.
(Name of Registrant as Specified in Charter)
|
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 14, 2013
|
By:
/s/ Hardy Hoheisel
|
|
|
Hardy Hoheisel, Chief Executive Officer
|
|
Explanation
It is anticipated that our net loss for the three months ended June 30, 2013 will be approximately $345,671 as compared to our net loss of $6,765 for the three months ended June 30, 2012, due to our material acquisition as of February 28, 2013 wherein we ceased to be a shell company and commenced operations in the field of devices that use spectroscopy to detect and measure substances within the body or other biological substances.
Rent, professional and other selling, general and administrative expenses increased for the three months ended June 30, 2013 over the year ended June 30, 2012 due to increased operations and accounting and related professional fees. Research and development increased for the three months ended June 30, 2013 over the three months ended June 30, 2012 due to our joint venture agreement with Opsolution GmbH. Other income (expense) increased due to increased travel expenses and filing and reporting requirements.